Dr. GPCR is evolving — one ecosystem, one mission.
From new University courses & the growing Dr. GPCR Foundry to Terry’s Pharmacology Corner & upcoming community events, we’re building with purpose — and with you. Read @yaminaberchiche latest note in↓
#DrGPCR#GPCR
...the weekend is coming! If you need something to listen to then try one of my @DrGPCR podcasts where I chat with @yaminaberchiche about starting off in a research career and how to maintain a growth and development mindset.
https://t.co/2jqP3UawsM
It is an honor and a pleasure to announce the Ulf von Euler lecturer 2025. So excited to host Madan M Babu at Karolinska for his lectureship award on Fri 7th of Nov 2025 in the Biomedicum lecture hall (G&E Klein Auditorium). https://t.co/B6l3MVLsWa
Kinetics > comfort. This week: Terry’s Corner on advanced kinetics, fluorescent ligands for flow cytometry, and a #DOT2025 speaker spotlight with Alison Heick Varghese & Kris Borzilleri.
Premium sneak peek inside. https://t.co/ovJVq9QYm1
#DrGPCR#GPCR
Last chance: GPCR Happy Hour Boston Sept 24. Scientists, CROs, investors — one room, one night. Register before it’s too late.
https://t.co/ZMoyrkhSTJ
#DrGPCR#GPCR#Biotech#Networking
Dr. GPCR x Revvity
Real-time GPCR internalization, reimagined.
Introducing pHSense™: 4 flexible formats, live-cell, no-wash, TRF-based. Now featured in the Dr. GPCR Ecosystem. 🎧 Plus: Behind the science w/ Dr. Trinquet.
🔗 https://t.co/Wd4e46yvTY
#GPCR#Revvity#Internalization
Sept 23–24: Aaron McGrath, PhD (Takeda), shares new PAR1/PAR2 structural insights. Watch my short interview→https://t.co/KP1QDe8oAD
Use code SPK200 for a discount before prices rise. I’ll chair a session with Dr. Terry Kenakin. #GPCR#DrGPCR
CROs: are hidden inefficiencies costing you sponsor trust?
Broken systems cause costly delays — not your scientists. Build precision into your operations before it hurts margins.
https://t.co/G8C8VYwlSV
#CROs#DrugDiscovery#GPCR
The panels will end. The real breakthroughs start here. 🥂 Join us Sept 24 for GPCR Happy Hour Boston. Space is limited.
https://t.co/ZMoyrkiqJh
#GPCR#DrGPCR#Biotech#BostonBiotech
Science isn’t just a career—it’s a calling. @CatDemery’s story shows why purpose, not prestige, is what sustains a life in academia.
🎧 Listen here: https://t.co/KqBCHpqM8J
#DrGPCR#GPCR
VCs & biotech leaders: how much runway is your GPCR program burning every day it’s stalled?
It’s not talent gaps. It’s broken systems. Fix the imprecision problem before it costs millions.
https://t.co/G8C8VYwlSV
#Biotech#VentureCapital#GPCR
Over 107,000 overdose deaths in 2023. Fentanyl is killing fast. Xylazine makes it harder to reverse.
PhD student @CatDemery is modeling how these drugs impair breathing — and why real-world data must shape our science.
👉 Listen now: https://t.co/KqBCHprjYh
#GPCR#DrGPCR
Is your GPCR program built for breakthroughs or breakdowns? My new blog series helps biotech leaders move beyond the "go fast" mindset. I provide precision scientific & operational guidance to accelerate discovery
Read Part 1 Link in the comments
#GPCR#Biotech#DrugDiscovery
Got good GPCR data but no momentum?
You're not alone! My latest blog post tackles this challenge & introduces Yamina's Consulting Services. Get insights on driving execution. #GPCR#Science
Read now: https://t.co/3afMxa1FV2